CYP2J2 and hepatocellular carcinoma: Finally, we aimed to investigate whether Hcy-mediated CYP2J2 might drive tumorigenesis in vivo by using a bioluminescence imaging system for sensitive detection of tumor growth in a mouse model of orthotopically induced HCC (Figure 7A).